-
Antibody Manufacturing Costs
-
Harnessing The Patient Voice in Real-World Evidence Opens in a new window)
The essential role of patient-reported outcomes.
-
Almost Half of All New Drug Approvals in 2018 Relied on One Clinical Trial Opens in a new window)
Forty-two percent of novel drugs (25 of 59) approved in 2018 were approved on the basis of only one trial.
-
J&J’s New Esketamine Drug for Depression, Spravato, not Worth the Money or the Risk, Watchdog Says Opens in a new window)
The cost of a ketamine infusion is usually not covered by most insurance companies and can run up to $800.
-
Prices Paid to Hospitals by Private Health Plans Are High Relative to Medicare and Vary Widely
Findings from an Employer-Led Transparency Initiative
-
Increase in Hepatitis A Virus Infections — United States, 2013–2018
-
1 Big Thing: How to Save $80 Billion a Year on Prescription Drugs Opens in a new window)
Medicare could have saved almost $80 billion, just in 2018, by matching the U.K.'s prices for prescription drugs that don't have any competition.
-
How to Save $45 Billion on Health Care Costs Each Year Opens in a new window)
Nearly 700,000 people get sick or die each year from infections they get in the hospital—most of which are preventable
-
Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO’s Budget Projections
Supplemental Material for Updated Budget Projections: 2019 to 2029
-
GoodRx Quarterly Report: Q1 2019
Over 500 brand name medications saw a list price increase in January, 2019.
-
Prevalence and Correlates of Medical Financial Hardship in the USA
-
Examining Healthcare
-
Medicare's Skyrocketing Specialty Drug Spending Opens in a new window)
There's been an explosion in spending on specialty drugs within Medicare's prescription drug benefit over the past decade, and it may be warping insurers' incentives to keep overall costs down.
-
We Need A National Conversation About Health — Not Just About Health Care Opens in a new window)
This question — Are we paying too much for health? — has defined much of the health conversation in the U.S. over the years. Unfortunately, it is the wrong question. Here’s the right one: Is our spending making us healthier?
-
What Study Findings? Most European Universities Fail to Report Clinical Trial Results Opens in a new window)
New survey finds results from more than four of every five studies run by 30 European universities have not been registered. Specifically, 83% of 940 clinical trials were missing results on the EU Clinical Trials Register.
